Journal retracts study tied to Micronoma’s effort to create cancer blood test
Nature retracted a high-profile paper that served as part of the scientific groundwork for Micronoma, a San Diego-based startup, on Wednesday. “Some of the findings
Nature retracted a high-profile paper that served as part of the scientific groundwork for Micronoma, a San Diego-based startup, on Wednesday. “Some of the findings
Makers of RSV vaccines for older adults saw their plans to try to expand usage hit a significant hurdle on Wednesday, when an expert committee
Emer Cooke, EMA’s Executive Director, also noted that there has been a rise in falsified versions of GLP-1 agonists, especially Ozempic. Image Credit: Alessandro Zappalorto
The Food and Drug Administration has drafted guidance aimed at getting drug companies and medical device makers to enroll more people of color and women
Eli Lilly will utilise the generative artificial intelligence from OpenAI to come up with new solutions for microbial infections. Credit: monticello via Shutterstock. Eli Lilly
Effective control of bovine schistosomiasis will be required to meet disease elimination targets in humans, new research shows.
A pilot study conducted by Kessler Foundation researchers has shown promising results in the use of methylphenidate to enhance oculomotor function in individuals with multiple
A significant new study published in the Cyborg Bionic Systems journal by Fanli Kong and colleagues sheds light on the intricate relationship between depression and
The National Comprehensive Cancer Network (NCCN)-;a nonprofit alliance of leading cancer centers-;is publishing new results for its latest survey on cancer drug shortages in the
Transgender women are still at risk for prostate cancer. A new study led by Cedars-Sinai Cancer investigators, published in the peer-reviewed Journal of the American